The Diabetic Foot

  • Dennis Shavelson


The importance of the physician’s role in examining and assessing the diabetic foot is hard to overstate.1 Fifteen percent of the 16 million diabetic patients in the United States will develop foot ulcers.2 The diabetic foot is responsible for more than half of the 67,000 annual non-traumatic lower extremity amputations in the developed world.3 Complications of the diabetic foot account for 25% of all diabetic hospital admissions in the USA.3 Lower extremity amputation is 15 times more likely to occur in a patient with diabetes and 50% of diabetic patients with an amputation have contralateral amputation within five years. The annual cost of amputations is $600 million and lost wages and morbidity are estimated at $1 billion, annually. Finally, studies have shown that primary care physicians are rarely performing foot examinations on their diabetic patients during routine visits.4,5


Diabetic Neuropathy Diabetic Peripheral Neuropathy Gamma Linoleic Acid Lower Extremity Amputation Gentian Violet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brenner MA, Ed. Management of the diabetic foot (chapter 6 ). Williams and Wilkins, New York, 1987.Google Scholar
  2. 2.
    The American Diabetes Association Advisory Board. Diab Care 17: 122–128, 1996.Google Scholar
  3. 3.
    Bulat T, Kosinski M. Diabetic foot: strategies to prevent and treat common problems. Geriatrics 46: 55–57, 1995.Google Scholar
  4. 4.
    Mayfield J. Foot examinations reduce the risk of diabetic amputations. J Fam Practice 49: 499–504, 1998.Google Scholar
  5. 5.
    American Diabetes Association. Foot care in patients with diabetes mellitus. Diab Care 21: 54–58, 1998.Google Scholar
  6. 6.
    Todd WF, Armstrong DG, Liswood PJ. Evaluation and treatment of the infected foot in a community teaching hospital. J Am Podiatr Med Assoc 86: 421–426, 1996.PubMedGoogle Scholar
  7. 7.
    LEAPP. Diabetes Care 21: 23–25, 1998.CrossRefGoogle Scholar
  8. 8.
    Armstrong DG, Lavery LA, Stern S, et al. Is prophylactic diabetes foot surgery dangerous? J Foot Ankle Surg, 35: 585–590, 1996.PubMedCrossRefGoogle Scholar
  9. 9.
    Glick JB. Dynamics of the foot in locomotion. Pod Management 4: 134–142, 2001.Google Scholar
  10. 10.
    Root ML, Orien WP and Weed JH. Normal and abnormal function of the foot. In Clinical biomechanics, Vol 2, Clinical Biomechanics Corp, LA, California, 1977.Google Scholar
  11. 11.
    Inman VT. The joints of the ankle. Mann/Inman, Ed. Williams and Wilkins, New York, 1976.Google Scholar
  12. 12.
    Donatelli R. The biomechanics of the foot and ankle. FA Davis Comp, Phila, PA, 1990.Google Scholar
  13. 13.
    Kevin KA. Biomechanics of the normal and abnormal foot. J Amer Pod Med Assoc 90: 88–92, 2000.Google Scholar
  14. 14.
    Shavelson D. The unequal limb syndrome: biomechanical considerations. J Am Acad Pod Sport Med 1: 18–23, 1983.Google Scholar
  15. 15.
    Caputo GM. The nylon monofilament test for sensation. New Eng J Med 331: 854–859, 1994.PubMedCrossRefGoogle Scholar
  16. 16.
    Frykberg R, Ed. The high risk foot in diabetes. Churchill Livingstone, New York, 1991.Google Scholar
  17. 17.
    Armstrong DG, Lavery LA, Harkless LB. Who is at risk for diabetic foot ulceration? Clin Podiatr Med Surg 15: 11–19, 1998.PubMedGoogle Scholar
  18. 18.
    Frykberg RG. Team approach toward lower extremity amputation prevention in diabetes. J Am Podiatr Med Assoc 87: 5–12, 1997.Google Scholar
  19. 19.
    Selby JV, Hang D. Risk factors for lower extremity amputation in persons with diabetes. Diab Care 18: 509–516, 1995.CrossRefGoogle Scholar
  20. 20.
    Day MR, Harkless LB. Factors associated with pedal ulceration in patients with diabetes mellitus. J Am Podiatr Med Assoc 87: 365–369, 1997.PubMedGoogle Scholar
  21. 21.
    Young MJ, Breddy JL, Veves A, et al. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diab Care 17: 557–562, 1994.CrossRefGoogle Scholar
  22. 22.
    McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diab Care 18: 216–219, 1995.CrossRefGoogle Scholar
  23. 23.
    Sykes MT, Godsey JB. Vascular evaluation of the problem diabetic foot. Clin Podiatr Med Surg 15: 49–83, 1998.PubMedGoogle Scholar
  24. 24.
    Apelqvist J. Wound healing in diabetes: outcome and costs. Clin Podiatr Med Surg 15: 21–39, 1998.PubMedGoogle Scholar
  25. 25.
    The Medicare Therapeutic Shoe Bill. Department of Health and Human Services, Medical Carriers Manual, Section 2134, p2–85.1–2–86. US Gov’t Printing Office, Washington, D.C., 1994.Google Scholar
  26. 26.
    Armstrong DG, et al. Continuous activity monitoring in persons at high risk for diabetes-related lower extremity amputation. J Am Pod Med Assoc 91: 451–455, 2001.Google Scholar
  27. 27.
    Lavery LA, Vela SA, Lavery DC, et al. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. Diab Care 19: 818–821, 1999.CrossRefGoogle Scholar
  28. 28.
    Shavelson D. Local anesthetics and injectable cortisone. In T Delauro, Ed. Clinics in Pod Med and Surg, Chapter 8, W.B. Saunders, Phila, 1993.Google Scholar
  29. 29.
    Jamal GA. The use of gamma linoleic acid in the prevention and treatment of diabetic neuropathy. Diab Medicine 11: 145–149, 1994.CrossRefGoogle Scholar
  30. 30.
    Hounsom L, et al. GLA is effective against multiple indices of experimental diabetic neuropathy. Diabetologia 41: 839–843, 1998.PubMedCrossRefGoogle Scholar
  31. 31.
    Resneck HE, et al. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age. Diab Care 23: 13 2138, 2000.Google Scholar
  32. 32.
    Marcinko DE. Antibiotic-impregnated polymethyl methacrylate beads. In Infections of the foot: diagnosis and management. Habershaw GM Ed. Mosby-Year Book Pub, St Louis, MO, 174–176, 1998.Google Scholar
  33. 33.
    Gibbons GW, Habershaw GM. Diabetic foot infections: anatomy and surgery. Infect Dis Clin North Am 9: 131–142, 1995.PubMedGoogle Scholar
  34. 34.
    Sommer TA. Charcot foot: the diagnostic dilemma. J Fam Practice 11: 1591–1599, 2001.Google Scholar
  35. 35.
    Frykberg RG. Diabetic foot ulcers: current concepts. J Foot Ankle Surg 37: 440–446, 1998.PubMedCrossRefGoogle Scholar
  36. 36.
    Sage RA. The management of foot ulcers. In Advances in podiatric medicine and surgery. W Joseph, Ed. Mosby-Year Book Pub, St. Louis, Mo 139–153, 1995.Google Scholar
  37. 37.
    Armstrong DG, Harkless LB, et al. Validation of a diabetic wound classification system: the importance of depth, infection and ischaemia, J Am Pod Med Assoc 79: 144–153, 1998.Google Scholar
  38. 38.
    Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diab Care 19: 1338–1342, 1996.CrossRefGoogle Scholar
  39. 39.
    Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 21: 822–829, 1998.PubMedCrossRefGoogle Scholar
  40. 40.
    Snyder RJ, Simonson DA. Cadaveric allograft as adjunct therapy for nonhealing wounds. J Foot Ankle Surg 38: 93–101, 1999.PubMedCrossRefGoogle Scholar
  41. 41.
    Falanga V. How to use Apligraf to treat venous ulcers. Skin and aging 2: 30–36, 1999.Google Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Dennis Shavelson

There are no affiliations available

Personalised recommendations